Newsletter
Mediracer in Japan
Mediracer entered to the Japanese Market in autumn 2013 in co-operation with a local distributor, MP Japan Co. Ltd. After two years of careful preparation, Mediracer Ltd achieved the registration of foreign manufacturer accreditation certification, certification of...
Mediracer in the UK
Mediracer UK Ltd, a subsidiary of Mediracer Oy (Finland), was established in August 2010. Prior to this, Mediracer’s products had been distributed in the UK by another company. Mediracer products have been in the UK market for over 7 years. Mediracer UK Ltd has built...
Nerve conducting testing has previously been the exclusive preserve of clinical neurophysiologists
Nerve conducting testing has previously been the exclusive preserve of clinical neurophysiologists although the tests performed are not complicated. There are nerve conduction tests which need specialist skills and equipment to be performed but the testing of the...
General hospital saved over £16,000 in less than a year using Mediracer NCS
The overall expenses in the healthcare sector have been rising a lot in the last years, but with Mediracer NCS the East Cheshire UK’s Macclesfield district general hospital was able to accumulate total overall saving of £16,850 between September 2009 and June 2010....
Monitoring of nervous system symptoms in diabetics
Oulu-based company Mediracer has released a measuring device to monitor the progress of degenerative nerve disease which commonly causes pain, loss of sensation and muscle dysfunction in diabetics. According to an American estimate, diabetic peripheral neuropathy...
Mediracer at the BSCN 2017 Autumn scientific Meeting, King's College Hospital, London
Mr. Andrew Larwood will attend the 2017 Autumn Scientific Meeting of the British Society for Clinical Neurophysiology
MDR-NCS-esite
UNE-process-guide
Attaching-CTS-electrode
Newsletter
Phone
+358 45 899 2626
info (at) mediracer.com
Location
Kasarmintie 13,
90130 Oulu
Finland